MX2023013683A - Compuestos de isoxazolilo fusionados como inhibidores de lisina acetiltransferasa 6a (kat6a). - Google Patents
Compuestos de isoxazolilo fusionados como inhibidores de lisina acetiltransferasa 6a (kat6a).Info
- Publication number
- MX2023013683A MX2023013683A MX2023013683A MX2023013683A MX2023013683A MX 2023013683 A MX2023013683 A MX 2023013683A MX 2023013683 A MX2023013683 A MX 2023013683A MX 2023013683 A MX2023013683 A MX 2023013683A MX 2023013683 A MX2023013683 A MX 2023013683A
- Authority
- MX
- Mexico
- Prior art keywords
- kat6a
- inhibitors
- compounds
- fused
- formula
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 125000000842 isoxazolyl group Chemical group 0.000 title 1
- 102100033071 Histone acetyltransferase KAT6A Human genes 0.000 abstract 2
- 101000944179 Homo sapiens Histone acetyltransferase KAT6A Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- -1 isoxazolyl compound Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención proporciona compuestos de isoxazolilo fusionados de fórmula (I), que son terapéuticamente útiles como inhibidores de KAT6A particularmente en el tratamiento y/o prevención de enfermedades o trastornos dependientes de KAT6A en un mamífero. La presente invención también proporciona la preparación de compuestos y composiciones farmacéuticas que comprenden al menos uno de los compuestos representados por la fórmula (I) o una sal farmacéuticamente aceptable o un estereoisómero o un tautómero de este.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN202141022736 | 2021-05-21 | ||
PCT/IB2022/054771 WO2022243983A1 (en) | 2021-05-21 | 2022-05-21 | Fused isoxazolyl compounds as kat6a inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2023013683A true MX2023013683A (es) | 2024-02-23 |
Family
ID=84140350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2023013683A MX2023013683A (es) | 2021-05-21 | 2022-05-21 | Compuestos de isoxazolilo fusionados como inhibidores de lisina acetiltransferasa 6a (kat6a). |
Country Status (10)
Country | Link |
---|---|
US (1) | US20240254139A1 (es) |
EP (1) | EP4341259A1 (es) |
JP (1) | JP2024521141A (es) |
KR (1) | KR20240012434A (es) |
CN (1) | CN117881677A (es) |
AU (1) | AU2022278733A1 (es) |
CA (1) | CA3221048A1 (es) |
IL (1) | IL308667A (es) |
MX (1) | MX2023013683A (es) |
WO (1) | WO2022243983A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20241355A1 (es) | 2021-11-16 | 2024-07-03 | Insilico Medicine Ip Ltd | Inhibidores de lisina acetiltransferasa 6a (kat6a) y usos de los mismos |
US20230303580A1 (en) | 2022-03-28 | 2023-09-28 | Isosterix, Inc. | Inhibitors of the myst family of lysine acetyl transferases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201810092D0 (en) * | 2018-06-20 | 2018-08-08 | Ctxt Pty Ltd | Compounds |
CR20210627A (es) * | 2019-06-18 | 2022-02-08 | Pfizer | Derivados de benzisoxazol sulfonimada |
-
2022
- 2022-05-21 CN CN202280043542.XA patent/CN117881677A/zh active Pending
- 2022-05-21 EP EP22804185.1A patent/EP4341259A1/en active Pending
- 2022-05-21 KR KR1020237042835A patent/KR20240012434A/ko unknown
- 2022-05-21 US US18/562,758 patent/US20240254139A1/en active Pending
- 2022-05-21 JP JP2023572216A patent/JP2024521141A/ja active Pending
- 2022-05-21 IL IL308667A patent/IL308667A/en unknown
- 2022-05-21 CA CA3221048A patent/CA3221048A1/en active Pending
- 2022-05-21 WO PCT/IB2022/054771 patent/WO2022243983A1/en active Application Filing
- 2022-05-21 MX MX2023013683A patent/MX2023013683A/es unknown
- 2022-05-21 AU AU2022278733A patent/AU2022278733A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2024521141A (ja) | 2024-05-28 |
KR20240012434A (ko) | 2024-01-29 |
AU2022278733A1 (en) | 2023-11-30 |
CA3221048A1 (en) | 2022-11-24 |
US20240254139A1 (en) | 2024-08-01 |
IL308667A (en) | 2024-01-01 |
EP4341259A1 (en) | 2024-03-27 |
CN117881677A (zh) | 2024-04-12 |
WO2022243983A1 (en) | 2022-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20237561B (en) | Protein tyrosine phosphatase inhibitors | |
CR20230310A (es) | Inhibidores de prmt5 | |
GEP20084439B (en) | Nitrogen-containing heterocyclic derivatives and pharmaceutical use thereof | |
EA200702339A1 (ru) | Замещенные амидные производные в качестве ингибиторов протеинкиназы | |
MX2022003102A (es) | Degradadores bifuncionales de brd9 y sus metodos de uso. | |
MX2023009222A (es) | Inhibidores tricíclicos-amido-bicíclicos de prmt5. | |
MX2023013683A (es) | Compuestos de isoxazolilo fusionados como inhibidores de lisina acetiltransferasa 6a (kat6a). | |
PH12021551256A1 (en) | Pantetheine derivatives and uses thereof | |
PH12019550140A1 (en) | Piperidine-substituted mnk inhibitors and methods related thereto | |
MX2021015854A (es) | Composiciones y métodos para tratar trastornos del snc. | |
MX2021011606A (es) | Compuestos dirigidos a prmt5. | |
MX2020001531A (es) | Nuevos compuestos hetorociclicos como inhibidores de cdk8/19. | |
EA201991916A1 (ru) | 1,4,6-ТРИЗАМЕЩЕННЫЕ-2-АЛКИЛ-1H-БЕНЗО[d]ИМИДАЗОЛЬНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ДИГИДРООРОТАТНЫХ ОКСИГЕНАЗНЫХ ИНГИБИТОРОВ | |
MX2021010122A (es) | Compuestos de imidazopiridinilo y su uso para el tratamiento de trastornos neurodegenerativos. | |
EA202190586A1 (ru) | N-замещенные диоксоциклобутениламино-3-гидроксипиколинамиды, приемлемые в качестве ингибиторов ccr6 | |
MX2020013297A (es) | Compuestos para el tratamiento o la prevencion de enfermedades hepaticas. | |
MX2021012105A (es) | Compuestos de pirrol. | |
MX2022007171A (es) | Compuestos cíclicos y métodos de uso de estos. | |
PH12019502652A1 (en) | 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases | |
MX2021003508A (es) | Derivados de 5-azaindazol como antagonistas del receptor de adenosina. | |
CO2023004420A2 (es) | Compuestos heterocíclicos como inhibidores del bromodominio cbp/ep300 | |
EA202190316A1 (ru) | Конденсированное производное лактама | |
MX2024002409A (es) | Terapias contra el cancer. | |
EA202192760A1 (ru) | Трициклические соединения | |
MX2021011081A (es) | Derivados de nicorandil. |